Log in
Enquire now
‌

US Patent 11197909 Compositions and methods for the treatment of fungal infections

Patent 11197909 was granted and assigned to Cidara Therapeutics on December, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Cidara Therapeutics
Cidara Therapeutics
Current Assignee
Cidara Therapeutics
Cidara Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11197909
Date of Patent
December 14, 2021
Patent Application Number
16629711
Date Filed
July 11, 2018
Patent Citations Received
‌
US Patent 11712459 Dosing regimens for treatment of fungal infections
0
‌
US Patent 11654196 Dosing regimens for echinocandin class compounds
0
Patent Primary Examiner
‌
Jeffrey E. Russel
Patent abstract

The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11197909 Compositions and methods for the treatment of fungal infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us